Encompass Health Co. (NYSE:EHC) Shares Sold by Leeward Investments LLC MA

Leeward Investments LLC MA decreased its position in shares of Encompass Health Co. (NYSE:EHC - Free Report) by 8.8% during the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 507,413 shares of the company's stock after selling 49,212 shares during the quarter. Encompass Health makes up approximately 2.3% of Leeward Investments LLC MA's holdings, making the stock its 2nd largest holding. Leeward Investments LLC MA owned about 0.50% of Encompass Health worth $49,036,000 as of its most recent filing with the SEC.

Several other large investors have also recently bought and sold shares of EHC. Vanguard Group Inc. lifted its stake in shares of Encompass Health by 1.7% in the 1st quarter. Vanguard Group Inc. now owns 10,166,147 shares of the company's stock valued at $839,520,000 after purchasing an additional 169,113 shares during the period. TD Asset Management Inc lifted its stake in shares of Encompass Health by 16.0% in the 1st quarter. TD Asset Management Inc now owns 2,283,674 shares of the company's stock valued at $188,586,000 after purchasing an additional 314,488 shares during the period. Dimensional Fund Advisors LP lifted its stake in shares of Encompass Health by 1.2% in the 2nd quarter. Dimensional Fund Advisors LP now owns 1,819,345 shares of the company's stock valued at $156,083,000 after purchasing an additional 22,311 shares during the period. Epoch Investment Partners Inc. lifted its stake in shares of Encompass Health by 14.2% in the 1st quarter. Epoch Investment Partners Inc. now owns 1,598,042 shares of the company's stock valued at $131,966,000 after purchasing an additional 198,701 shares during the period. Finally, 8 Knots Management LLC lifted its stake in shares of Encompass Health by 14.0% in the 1st quarter. 8 Knots Management LLC now owns 1,288,815 shares of the company's stock valued at $106,430,000 after purchasing an additional 158,356 shares during the period. Institutional investors and hedge funds own 97.25% of the company's stock.

Insider Buying and Selling at Encompass Health

In other Encompass Health news, CFO Douglas E. Coltharp sold 12,260 shares of the firm's stock in a transaction on Tuesday, August 13th. The stock was sold at an average price of $86.34, for a total transaction of $1,058,528.40. Following the completion of the sale, the chief financial officer now owns 136,227 shares of the company's stock, valued at $11,761,839.18. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Insiders own 2.10% of the company's stock.

Encompass Health Stock Up 1.6 %

Shares of EHC traded up $1.62 during mid-day trading on Thursday, hitting $103.53. 693,716 shares of the company's stock were exchanged, compared to its average volume of 642,978. The company has a market cap of $10.43 billion, a PE ratio of 24.62, a P/E/G ratio of 1.32 and a beta of 0.88. Encompass Health Co. has a 52 week low of $62.58 and a 52 week high of $103.89. The company has a 50-day simple moving average of $95.07 and a 200 day simple moving average of $89.34. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 1.35.

Encompass Health (NYSE:EHC - Get Free Report) last issued its quarterly earnings results on Monday, October 28th. The company reported $1.03 earnings per share for the quarter, topping the consensus estimate of $0.94 by $0.09. Encompass Health had a net margin of 8.10% and a return on equity of 17.60%. The company had revenue of $1.35 billion during the quarter, compared to analysts' expectations of $1.33 billion. During the same period last year, the business earned $0.86 EPS. The business's quarterly revenue was up 11.9% on a year-over-year basis. On average, research analysts forecast that Encompass Health Co. will post 4.29 earnings per share for the current fiscal year.

Encompass Health announced that its board has authorized a share buyback program on Wednesday, July 24th that permits the company to buyback $500.00 million in shares. This buyback authorization permits the company to reacquire up to 5.4% of its shares through open market purchases. Shares buyback programs are typically a sign that the company's board believes its shares are undervalued.

Encompass Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, January 15th. Investors of record on Thursday, January 2nd will be paid a $0.17 dividend. The ex-dividend date is Thursday, January 2nd. This represents a $0.68 annualized dividend and a dividend yield of 0.66%. Encompass Health's dividend payout ratio is presently 16.43%.

Analyst Upgrades and Downgrades

A number of research firms have recently weighed in on EHC. Royal Bank of Canada increased their price target on Encompass Health from $105.00 to $110.00 and gave the company an "outperform" rating in a research note on Wednesday, October 30th. Leerink Partners assumed coverage on Encompass Health in a report on Wednesday, July 10th. They set an "outperform" rating and a $100.00 target price on the stock. Leerink Partnrs upgraded Encompass Health to a "strong-buy" rating in a report on Wednesday, July 10th. UBS Group boosted their price objective on Encompass Health from $100.00 to $110.00 and gave the company a "buy" rating in a research report on Wednesday, September 25th. Finally, KeyCorp increased their target price on Encompass Health from $115.00 to $117.00 and gave the stock an "overweight" rating in a research note on Tuesday, October 29th. Nine research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company's stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Buy" and a consensus price target of $107.11.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.